Allergan, Inc. (AGN) · page 98 of 110
The slide uses a hypothetical scenario to justify a valuation premium based on asset acquisition scale.
Activist deck · valuation_table · show_valuation_bridge · dense density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 legend 1/1 paragraph 1/1 source-note 1/1 table 1/1 title 1/1
Components 6
primary legend paragraph source-note valuation headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1